| Tag | Content |
|---|
EnhancerAtlas ID | HS120-01772 |
Organism | Homo sapiens |
Tissue/cell | LNCaP-abl |
Coordinate | chr13:114301640-114302450 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| E2F6 | MA0471.1 | chr13:114302067-114302078 | CTTTCCCGCCC | - | 6.32 | | NR2C2 | MA0504.1 | chr13:114301751-114301766 | TCACCTCTGACCTCT | - | 6.88 | | NR2C2 | MA0504.1 | chr13:114301758-114301773 | TGACCTCTGACCTTC | - | 7.33 | | Nr2f6 | MA0677.1 | chr13:114301758-114301772 | TGACCTCTGACCTT | - | 7.28 | | Rxra | MA0512.2 | chr13:114301758-114301772 | TGACCTCTGACCTT | - | 6.62 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_41872 | chr13:114301246-114302949 | LNCaP |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH13I113647 | chr13 | 114301216 | 114302896 |
|
Enhancer Sequence | GGCTCTGGGT GGCCATGGGA CACGTGGCAG GCGTGTTGGG TTCCAGCTGG GTTGGCTTTG 60
AGAGTCTGGT GGGATGAACC CTCATGGCTC CACCGTCACT TTGAGGTGGT GTCACCTCTG 120
ACCTCTGACC TTCAGCATGG CATGACCTCG CTGAGGTGAC CCTGGTGTCC CACATATCAC 180
CCTGAGTGTT CTTAATACAC AGTCGAGGGC TGTGTTCATT GGACTATTCT GGTGTCACCG 240
CCCACTTCAT TTCTGTGCCT GGCAGCACTT TTACTCCTGG TTGGGAGCAT GACCGCCTCC 300
CAGTTCAGCT TCCTCCTGCG TCCCAAGTGA GCGGGGCGGC TGTCCTCGAG GACTCCGGGC 360
TCACAGCCAA CCTGCTGGCA CGGCTCGAGG ACTCCGGGCT CACAGCCAAC CTGCTGGCAC 420
GGCCGCCCTT TCCCGCCCTG CCTCGGGTGA GCCAAGGACT TGTCTTCTGC TTCCTGGGTT 480
CCTGAAAGAG CTCTCCTCTG ATTTCTCAAA GGCAAAATAA AACTCAGATT TAAGTCTTTG 540
GTGCGTAGCC CCTAATTTCC TTCCCTTTCT CTGAATCCTC ACTGCCCAGC ATGATGGACC 600
GGCCTGGGCT CAGGACCTGA TTCCACAGGC TCCCAGCCCT CCCACAGGTA CCGTGTCTTC 660
TGTGCTGGTG TCGCACCCGC CGGCCACCGC CACCCTGCGT CTTAGACGTC CCGCCGCAGC 720
TGTGTTTCCA CCTCATCTCC AGCTTGAGTG GCAGCCAGCG GCGCCACCTG CACACGAGCC 780
CCCTCCATTC GAGAAGCACA GACTATGAGT 810
|
